1. Fixation using Alternative Implants for the Treatment of Hip Fractures (FAITH-2): The Exploratory Health-Related Quality of Life and Patient-Reported Functional Outcomes of a Multi-Centre 2 × 2 Factorial Randomized Controlled Pilot Trial in Young Femoral Neck Fracture Patients. Issue 10 (October 2021) Authors: Slobogean, Gerard P.; Sprague, Sheila; Bzovsky, Sofia; Scott, Taryn; Thabane, Lehana; Heels-Ansdell, Diane; O'Toole, Robert V.; Howe, Andrea; Gaski, Greg E.; Hill, Lauren C.; Brown, Krista M.; Viskontas, Darius; Zomar, Mauri; Della Rocca, Gregory J.; O'Hara, Nathan N.; Bhandari, Mohit; Malekzadeh... Journal: Injury Issue: Volume 52:Issue 10(2021) Page Start: 3051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial. Issue 3 (March 2022) Authors: Fennell, Dean A; King, Amy; Mohammed, Seid; Greystoke, Alastair; Anthony, Sarah; Poile, Charlotte; Nusrat, Nada; Scotland, Molly; Bhundia, Vina; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Bajaj, Amrita; Richards, Cathy; Wells-Jord... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial. Issue 6 (June 2021) Authors: Fennell, Dean A; King, Amy; Mohammed, Seid; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Nicholson, Adrian; Richards, Cathy; Wells-Jordan, Peter; Murphy, Gavin James; Thomas, Anne; Fennell, Dean Anthony; King, Amy; Mohammed, Seid; B... Journal: Lancet Issue: Volume 9:Issue 6(2021) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Human Antigen R (HuR) as a therapeutic target in pathological cardiac hypertrophy. (November 2018) Authors: Green, Lisa; Anthony, Sarah; Slone, Samuel; Lanzillotta, Lindsey; Nieman, Michelle; Wu, Xiaoquing; Robbins, Nathan; Jones, Shannon; Rubinstein, Jack; Lorenz, John; Blaxall, Burns; Xu, Liang; Benoit, Joshua; Tranter, Michael Journal: Journal of molecular and cellular cardiology Issue: Volume 124(2018) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗